Processing math: 100%

Details

Hkratni preizkusi neinferiornosti : delo diplomskega seminarja
ID Šraj, Eva (Author), ID Smrekar, Jaka (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (527,71 KB)
MD5: B508543CB0F5880B89BCA0D9D9289A4F

Abstract
Diplomska naloga temelji na preizkušanju domnev glede učinkovitosti treh med seboj neodvisnih skupin zdravljenj -- eksperimentalno zdravljenje (E), referenčno zdravljenje (R) in zdravljenje s placebom (P). Pomembni predpostavki hkratnega preizkušanja domnev sta homoskedastičnost in normalnost. Opazovanje k-tega bolnika v skupini i je označeno z Xik in porazdeljeno XikN(μi,σ2), za i=E,P,R; k=1,,ni. Oznaka ni predstavlja število bolnikov posamezne vrste zdravljenja i, δij0 dopustno odstopanje, za i=E,P,R; ij, zα pa zgornji α-percentil standardne normalne porazdelitve. Z zavrnitvijo glavne ničelne domneve H0 dokažemo superiornost eksperimentalnega zdravljenja (E) nad zdravljenjem s placebom (P) in hkrati neinferiornost eksperimentalnega (E) proti referenčnemu zdravljenju (R). Asimptotična moč za zavrnitev H0 je enaka ΦΣ(μEμPδEPσ1nE+1nPzα,μEμR+δERσ1nE+1nRzα). Z zavrnitvijo razširjene ničelne domneve ˜H0 dokažemo še superiornost referenčnega zdravljenja (R) nad zdravljenju s placebom (P). Asimptotična moč za zavrnitev ˜H0 pri stopnji značilnosti α je enaka Φ˜Σ(μEμPδEPσ1nE+1nPzα,μEμR+δERσ1nE+1nRzα,μRμPδRPσ1nR+1nPzα).

Language:Slovenian
Keywords:neinferiornost, načelna superiornost, asimptotična moč, združena cenilka, vzorčna varianca, zvezno porazdeljeni podatki
Work type:Final seminar paper
Typology:2.11 - Undergraduate Thesis
Organization:FMF - Faculty of Mathematics and Physics
Year:2019
PID:20.500.12556/RUL-109975 This link opens in a new window
UDC:519.2
COBISS.SI-ID:18740057 This link opens in a new window
Publication date in RUL:11.09.2019
Views:2376
Downloads:283
Metadata:XML DC-XML DC-RDF
:
ŠRAJ, Eva, 2019, Hkratni preizkusi neinferiornosti : delo diplomskega seminarja [online]. Bachelor’s thesis. [Accessed 17 May 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=109975
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Simultaneous non-inferiority trials
Abstract:
This work is based on hypothesis testing regarding efficacy of 3 independent groups of treatment -- experimental treatment (E), active reference (R) and placebo (P). The important assumptions here are homoscedasticity and normality. The observation for the kth patient in group i is denoted as Xik and is distributed as XikN(μ,σ2), for i=E,P,R; k=1,,ni. The symbol ni represents the number of patients in group i, δij0 the inferiority/superiority margin, for i=E,P,R; ij and zα upper α-percentile of standard normal distribution. With the rejection of the principal null hypothesis H0 we prove the superiority of experimental treatment (E) versus placebo (P) and, simultaneously, non-inferiority of experimental treatment (E) versus active reference (R). The asymptotic power for the rejection of H0 equals ΦΣ(μEμPδEPσ1nE+1nPzα,μEμR+δERσ1nE+1nRzα). With the rejection of the extended null hypothesis ˜H0 we prove, in addition, the superiority of active reference (R) versus placebo (P). The asymptotic power for the rejection of ˜H0 equals Φ˜Σ(μEμPδEPσ1nE+1nPzα,μEμR+δERσ1nE+1nRzα,μRμPδRPσ1nR+1nPzα).

Keywords:non-inferiority, superiority, asymptotic power, pooled estimator, sample variance, continuous data

Similar documents

Similar works from RUL:Searching for similar works...Please wait....
Similar works from other Slovenian collections:

Back